Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

• Status: Terminated
• Trial end date: 2009-02-01

Summary

This study will test the effectiveness and the safety of giving two antifungal agents (voriconazole and anidulafungin) together to treat invasive aspergillosis in patients who are unable to tolerate polyene therapy.

• Phase: Phase 4

Details

• Lead Sponsor: Pfizer
• Treatments: Anidulafungin; Echinocandins; Voriconazole